Geodon 20mg/ml Injection
PDF Leaflet Revision Date: 12 August 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acute agitation in schizophrenic patients.
Dosage (summary)
10-20 mg IM, max 40 mg/day; doses of 10 mg may be given every 2 hours.
Onset of Action / Duration
Onset: 30-60 mins, Duration: 2-5 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended; teratogenicity shown in animals; unknown if excreted in breast milk.
Key Drug Interactions
- Class IA and III anti-arrhythmics
- CNS depressants
- QT prolonging drugs
Contraindications
- Hypersensitivity to ziprasidone
- QT interval prolongation
- Recent myocardial infarction
- Uncompensated heart failure
Common side effects
- Injection site pain
- Nausea
- Somnolence
- Dizziness
Counselling Points
- Avoid driving until effects are known
- Monitor for QT prolongation
- Use contraception if of childbearing potential
Serious warnings
- QT prolongation risk
- Neuroleptic Malignant Syndrome
- Severe cutaneous adverse reactions
Important Disclaimer
The Geodon 20mg/ml Injection professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
